Arrowhead Pharmaceuticals Stock Filter Stocks by Fundamentals
| ARWR Stock | USD 14.96 0.25 1.70% |
Fundamental analysis of Arrowhead Pharmaceuticals allows traders to better anticipate movements in Arrowhead Pharmaceuticals' stock price by examining its financial health and performance throughout various phases of its business cycle.
Arrowhead | Shares Owned by Institutions | Build AI portfolio with Arrowhead Stock |
Arrowhead Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Arrowhead Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Arrowhead Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Arrowhead Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Arrowhead Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arrowhead Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arrowhead Pharmaceuticals' value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.8 M | Goldman Sachs Group Inc | 2025-03-31 | 1.7 M | Ubs Group Ag | 2025-03-31 | 1.6 M | Northern Trust Corp | 2025-03-31 | 1.2 M | Aberdeen Group Plc | 2025-03-31 | 1.1 M | Charles Schwab Investment Management Inc | 2025-03-31 | 1 M | Citadel Advisors Llc | 2025-03-31 | 987 K | Two Sigma Investments Llc | 2025-03-31 | 835.2 K | Western Financial Corp/ca | 2025-06-30 | 820.2 K | Blackrock Inc | 2025-03-31 | 19.9 M | Vanguard Group Inc | 2025-03-31 | 13.2 M |
Arrowhead Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.0586 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | 0.70 % | ||||
| Current Valuation | 1.36 B | ||||
| Shares Outstanding | 138.1 M | ||||
| Shares Owned By Insiders | 13.02 % | ||||
| Shares Owned By Institutions | 77.14 % | ||||
| Number Of Shares Shorted | 12.62 M | ||||
| Price To Earning | 482.39 X | ||||
| Price To Book | 3.02 X | ||||
| Price To Sales | 4.03 X | ||||
| Revenue | 3.55 M | ||||
| Gross Profit | 545.21 M | ||||
| EBITDA | (561.51 M) | ||||
| Net Income | (609.69 M) | ||||
| Cash And Equivalents | 416.5 M | ||||
| Cash Per Share | 3.93 X | ||||
| Total Debt | 510.55 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 3.37 X | ||||
| Book Value Per Share | 4.95 X | ||||
| Cash Flow From Operations | (462.85 M) | ||||
| Short Ratio | 8.03 X | ||||
| Earnings Per Share | (1.24) X | ||||
| Price To Earnings To Growth | (1.32) X | ||||
| Target Price | 44.0 | ||||
| Number Of Employees | 609 | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 2.2 B | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | (1.63 B) | ||||
| Working Capital | 592.3 M | ||||
| Current Asset | 90.5 M | ||||
| Current Liabilities | 25.64 M | ||||
| Net Asset | 1.14 B |
About Arrowhead Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arrowhead Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Arrowhead Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Arrowhead Stock
| 0.71 | VRDN | Viridian Therapeutics | PairCorr |
| 0.8 | VTYX | Ventyx Biosciences | PairCorr |
| 0.8 | PFE | Pfizer Inc | PairCorr |
| 0.76 | MRVI | Maravai Lifesciences | PairCorr |
Moving against Arrowhead Stock
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.